Leo Pharma INC
3 recalls on record · Latest: Mar 4, 2026
Subscribe to new Leo Pharma INC recalls (RSS)
Agency notice ledger
Federal filing book Leo Pharma INC LIGHT-BOOK · SINGLE-AGENCY
#3,778 of 14,151 · 3 notices · 0.003% archive
- BOOK 3 notices
- RANK #3,778 of 14,151
- SHARE 0.003% archive
- AGENCY FDA Drug (3)
- CAT drugs
- CATS 1 category
- LATEST Mar 4, 2026
- PHOTO 3B Medical, Inc.
Nearest notice-volume peer: 3B Medical, Inc. (0 notice gap)
Leo Pharma INC accounts for about 0.003% of the 104,423-notice archive on 3 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →
Where Leo Pharma INC sits among 14,151 recalling firms
Leo Pharma INC ranks 3,778th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.
Leo Pharma INC vs all firms by recall-notice count
Where this firm's archive sits among every tracked recalling manufacturer
3 3778th of 14151 higher than 9,908 of 14,151 firms
Firms, banded by distinct federal recall-event inventory
Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-14
Leo Pharma INC in the notice-volume neighbourhood
Distinct federal recall events among this firm and nearest nationwide peers
- Leo Pharma INC (this)
Leo Pharma INC
3 notices
- 3B Medical, I…
3B Medical, Inc.
3 notices
- 7-Eleven, Inc.
7-Eleven, Inc.
3 notices
- A & C Best Fo…
A & C Best Food Trading
3 notices
- A B Nutrition…
A B Nutrition, Inc.
3 notices
- A L I Technol…
A L I Technologies Ltd
3 notices
What this shows Leo Pharma INC holds about 0.003% of archive notices alongside 3 distinct filings.
Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPLE NOT FOR SALE, NDC 50222-350-91; b) 2 x Single dose Autoinjectors, NDC 50222-350-02; Rx only, Manufactured by: LEO Pharma A/S. Industriparken 55, DK-2750 Ballerup, Denmark, Distributed by: LEO Pharma Inc., Madison, NJ 07940, USA,
Calcipotriene Cream 0.0005%, packaged in a) 60g tube, (NDC 66993-877-61), b) 120g tube (NDC 66993-877-78), Rx Only, Manufactured by: LEO Pharma Inc., Dublin, Ireland, Manufactured for: Prasco Laboratories, Mason, OH, 45040
Taclonex (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064%, packaged in (a) 60 g (NDC 50222-501-06), and (b)120 g (50222-501-66) tubes, Rx Only, Manufactured by: LEO Laboratories Ltd., 285 Cashel Road, Dublin 12 Ireland, Distributed by: LEO Pharma Inc. 1 Sylvan Way, Parsippany, NJ 07054.
Leo Pharma INC is a small archive contributor
Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.
Similar recall count
Nearest multi-notice firms by distinct-event totals (3 here).
Similar drugs volume
Nearest multi-notice firms in the same narrow category lane.
Frequently Asked Questions
How many federal recall notices name Leo Pharma INC? ▼
Where does Leo Pharma INC sit among other recalling firms? ▼
Which agency issues most of Leo Pharma INC's notices? ▼
What product category dominates Leo Pharma INC's filing book? ▼
Is a higher notice count more dangerous? ▼
Firm-level totals aggregate distinct federal recall events naming Leo Pharma INC; individual notices remain authoritative on each linked recall page.
Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026